Related Experiment Video
Updated: Jul 4, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Treatment of chronic viral hepatitis]
Court Pedersen1, Christian Ross Pedersen
1Odense Universitetshospital, Infektionsmedicinsk Afdeling Q, Odense C. court.pedersen@ouh.regionsyddanmark.dk
Abstract:
Interferon-alfa is used for the treatment of chronic viral hepatitis. The best results for HCV are obtained with pegylated interferon-alpha in combination with the antiviral drug ribavirin. Sustained response (cure) is obtained in 40% (genotype 1) to 85% (genotype 2 or 3) of treated patients. Interferon-alpha has many side effects, and the selection of patients for treatment should be made taking into consideration the individual prognosis and relative and absolute contraindications. New biologics are in clinical development.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis
Chronic Pancreatitis II: Collaborative Care
Assessment:
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors
